Can in vitro assessment provide relevant end points for cognitive drug programs?

By Albensi Benedict C  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1377-1382

Informa Healthcare

Access to resources Recommend Favorite

In vitro immunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response

By Drynda Angelika   Mączyński Marcin   Ryng Stanisław   Obmińska-Mrukowicz Bożena  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 150-157

Informa Healthcare

Access to resources Recommend Favorite

Simple and efficient model systems of screening anti-Toxoplasma drugs in vitro

By Jin Chunmei   Jung Suk-Yul   Kim Sung Yeon   Song Hyun-Ok   Park Hyun  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 3, 2012-03 ,pp. : 195-205

Informa Healthcare

Access to resources Recommend Favorite

Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity

By de Campos Angela M.   Diebold Yolanda   Carvalho Edison L. S.   Sánchez Alejandro   José Alonso Maria  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 803-810

Springer Publishing Company

Access to resources Recommend Favorite

Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time

By Vauquelin Georges  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 927-941

Informa Healthcare

Access to resources Recommend Favorite